News Briefs

By AIS Health Staff

CVS Health Corp. said on March 31 that its PBM division Caremark will “continue to serve the government-wide Service Benefit Plan” in a deal effective Jan. 1, 2022. The contract is an arrangement with carriers of the Federal Employees Health Benefits program and adds specialty drug management to Caremark’s existing contract providing retail, mail and clinical pharmacy services. Prime Therapeutics LLC previously held the specialty contract. Read more at https://bit.ly/3t11yfk.

After replacing Novartis’ psoriasis drug Cosentyx (secukinumab) with Eli Lilly and Co.’s Taltz (ixekizumab) on most of its 2021 formularies, Cigna Corp. is offering a financial incentive for recalcitrant patients to switch to the cheaper drug. In March, the insurer sent a letter advising doctors that patients could receive a $500 debit card if they switch from Cosentyx to Taltz or an older biologic before Aug. 31 and then refill the prescription before Dec. 31, according to the American Journal of Managed Care. Visit https://bit.ly/3wBh0kJ.

© 2024 MMIT
AIS Health Staff

AIS Health Staff

Related Posts

insulin-injection
April 11

Current Market Access to GLP-1s

READ MORE
ruler
April 11

Wegovy’s New Indication Turns Up Heat on Employers Sweating GLP-1 Costs

READ MORE
cvs-health-building
April 11

Big Three PBMs Cover Opill With $0 Cost Sharing for Most Commercial Plans

READ MORE

GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND

Sign up for publications to get unmatched business intelligence delivered to your inbox.

subscribe today